https://www.selleckchem.com/mTOR.html
20, CI 2.90-3.51). Risk was greatest following a stillbirth (RR 5.82 (95% CI 4.97, 6.81)). For CTD and SLE, the risk was greatest within the first 5 years of adverse pregnancy outcome. Risk for aPL and APS diagnosis was highest ≥ 5 years from adverse pregnancy outcome. CONCLUSIONS Adverse pregnancy outcome is associated with increased risk of developing maternal CTD, including SLE. Either immunological factors predispose women to adverse pregnancy outcome and subsequent CTD diagnosis, or alternatively, adverse pregnancy outcome initiates autoimmune